Peer-reviewedCC BY-NC-NDTranslational cancer research
Cellular immunotherapy for lung cancer: current clinical evidence, translational challenges, and future perspectives: a narrative review
- 1College of Clinical Medicine , Qinghai University , Xining , ;
- 2Department of Medical Oncology I , The Fifth People’s Hospital of Qinghai Province , Xining ,
Related
- A narrative review of barrier-matched engineering of macrophages for solid tumor immunotherapy: design logic, translational barriers and clinical outlook
- Low-energy extracorporeal shock wave therapy for interstitial cystitis/bladder pain syndrome: mechanisms, evidence, and translational perspectives—a narrative review
- Natural Product-Derived Hydrogels for Myocardial Infarction Repair: Mechanisms, Challenges, and Translational Perspectives
- Immunomodulatory potential of Mongolian medicine in sepsis: current evidence, challenges, and translational perspectives
- A narrative review of stem cell-based therapy for fibrosing interstitial lung diseases: clinical evidence and translational perspectives
BibTeX
@article{ma2026cellular,
title = {{Cellular immunotherapy for lung cancer: current clinical evidence, translational challenges, and future perspectives: a narrative review}},
author = {Nannan Ma and Chunxiang Shang},
journal = {Translational cancer research},
year = {2026},
month = aug,
url = {https://europepmc.org/article/PMC/PMC13657804},
note = {CC BY-NC-ND},
}
RIS
TY - JOUR
TI - Cellular immunotherapy for lung cancer: current clinical evidence, translational challenges, and future perspectives: a narrative review
AU - Nannan Ma
AU - Chunxiang Shang
PY - 2026
DA - 2026/08/31
JO - Translational cancer research
UR - https://europepmc.org/article/PMC/PMC13657804
SN - 2218-676X
ER -